More Polynovo Limited news
Polynovo LimitedASX: PNV

First patient enrolled in Pivotal Trial - BARDA

Sep 21, 2021 at 4:14 AM EDT · Issued by Polynovo Limited

Filed with ASX · Sep 21, 2021 at 4:14 AM EDT

On 6ix: 6ix.com/news/first-patient-enrolled-in-pivotal-trial-barda

Watch Polynovo's latest call↗Polynovo (ASX:PNV) Q4 2026 Earnings Call · Replay · Aug 25Read the transcript of Polynovo (ASX:PNV) Q4 2026 Earnings Call↗

Polynovo Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Polynovo Limited on 6ix

Story so far

  • USA FDA approves Pivotal Trial IDENov 13, 2020
  • BARDA funding for Pivotal TrialJul 14, 2020
  • Pivotal Trial Protocol - UpdateJul 10, 2020

Earlier from Polynovo

  • FY21 Results PresentationAug 26, 2021
  • Appendix 4E and FY21 Financial StatementsAug 26, 2021
  • FY21 BTM Revenue ResultsJul 12, 2021
  • PolyNovo signs with Premier Inc. (GPO)Mar 25, 2021
  • Distributor App. - PolyNovo enters Denmark, Norway & IcelandFeb 24, 2021

Later from Polynovo

  • COVID Trading Themes - Q1 FY22 UpdateOct 20, 2021
  • Chairman and Managing Director - AGM addressOct 26, 2021
  • Q1 FY22 Trading Update - Clarification AnnouncementOct 29, 2021
  • Managing Director resignationNov 5, 2021
  • Record US sales in July and Nov, and other mattersDec 13, 2021
All Polynovo news releases↗

Follow Polynovo into a list and get an email when it puts out news.

Follow Polynovo
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer